Biological Industries is now part of the Sartorius group. Click here for more

BIO-AMF™-3 Medium

Optimized for increased metaphase yield in the primary culture of human amniotic fluid cells and chorionic villi samples

Will be discontinued from 1/10/2022
Name SKU Size
BIO-AMF™-3 Complete Medium 01-196-1A 500 mL
BIO-AMF™-3 Complete Medium 01-196-1B 100 mL

Description

Details

Product Overview:

BIO-AMF™-3 Complete Medium is a is a further optimized, fully supplemented medium featuring an enhanced buffering system, improved banding quality, increased metaphase yield and reduction in epithelial cell colonies. This medium accelerates the growth of the non-epithelial cells used for chromosome karyotyping.

Advantages

  • Ready-to-use
    Single bottle formulation, complete with L-Glutamine and Gentamycin that is shipped frozen. Upon receipt, simply thaw and use. We recommend storing thawed medium at 2-8°C for up to fourteen days.
  • Quality and performance testing
    Evaluated for cell growth using primary human amniotic fluid cells from a leading clinical cytogenetics laboratory. Each batch is tested for sterility, pH, osmolality and endotoxin concentrations.
  • Optimized and complete solution
    Prepared with Fetal Bovine Serum (FBS), L-Glutamine and Gentamycin optimized for both open (CO2) and closed systems.


Product Use: For human amniotic and chorionic villus samples

cGMP Manufacturing and Quality System Manufactured at our cGMP compliant facility, located in Beit Haemek, Israel. The facility is registered with the FDA as a medical device manufacturer and is certified to ISO 13485 standards.

Specifications

Specifications

Brand BIO-AMF™
Form Liquid
cell type Amniocytes
Glutamine L-Glutamine
antibiotics Gentamycin
Shipping Conditions Dry Ice
Storage Conditions -20ºC
shelf life 36 months from date of production and stored frozen

After thawing, 14 days at 2°C to 8°C

References

references

  1. W. Tancharoen et al. Human platelet lysate as an alternative to fetal bovine serum for culture and endothelial differentiation of human amniotic fluid mesenchymal stem cells Molecular Medicine Reports, April 22, 2019 https://doi.org/10.3892/mmr.2019.10182, 5123-5132
  2. H. Zhang, Instrument-Dependent or Instrument-Independent Indications and Prevalence of Chromosomal Abnormalities by Amniocentesis in China: An Analysis of 4146 Cases of Amniocentesis  Proceedings of Anticancer Research, Vol 2 No 2 (2018)
  3. Z. Hu, et al. Down-regulated WDR35 contributes to fetal anomaly via regulation of osteogenic differentiation Science Direct,1 February 2019, https://doi.org/10.1016/j.gene.2019.02.034 
  4. L. Giordani, et al. High-Dimensional Single-Cell Cartography Reveals Novel Skeletal Muscle-Resident Cell Populations Molecular Cell, Volume 74, Issue 3, 2 May 2019, Pages 609-621
  5. T. Laowanitwattana, et al. Osteoblastic differentiation potential of human amniotic fluid-derived mesenchymal stem cells in different culture conditions  Science Direct, Volume 120, Issue 8, November 2018, Pages 701-712
  6. S. Narakornsak, et al. Amniotic fluid: Source of valuable mesenchymal stem cells and alternatively used as cryopreserved solution Science Direct, Volume 121, Issue 1, January 2019, Pages 72-83 

Documentation

Materials Safety Data Sheet

Manuals and Protocols

Product Information

Certificate of Analysis

Certificates of Analysis (COA's) describe quality control data for specific product lots.

COA's can be downloaded from Sartorius's Certificates Portal.

For certificates issued before November 15, 2021, please enter below the product lot number and click search.
If your search does not return any results, please contact us for assistance.

Reviews

Write Your Own Review

You're reviewing: BIO-AMF™-3 Medium

How do you rate this product? *

  1 star 2 stars 3 stars 4 stars 5 stars
Quality

You may also be interested in the following product(s)